Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Oxford Nanopore Technologies (ONT) Share News

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

22nd Jan 2024 09:34

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC. Read More

LONDON BROKER RATINGS: Exane BNP cuts BAE; Liberum lifts Naked Wines

18th Jan 2024 09:16

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday: Read More

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

16th Jan 2024 09:14

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning: Read More

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

10th Jan 2024 09:35

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday: Read More

Oxford Nanopore expects 2023 revenue growth despite slump in sales

9th Jan 2024 09:26

(Alliance News) - Oxford Nanopore Technologies PLC on Tuesday said it expects an annual jump in revenue despite a slowdown in growth in some areas of the company. Read More

IN BRIEF: IP Group sets GBP20 million share buyback to cut cash pile

18th Dec 2023 11:10

IP Group PLC - invests in companies pursuing breakthrough science and innovation, such as Oxford Nanopore Technologies PLC - Launches on Monday a share buyback worth up to GBP20 million. The programme conducted by Deutsche Numis, part of Deutche Bank AG, will run until the end of 2024. IP Group says it has gross cash of GBP235 million as of November 30, following GBP38 million in cash realisations. At the same time, the company notes the discount of its share price to net asset value, which was reported at 126.7 pence per share at the half-year stage of 2023 on June 30. Read More

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

5th Dec 2023 10:02

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday: Read More

Oxford Nanopore hails funding for research group using its technology

30th Nov 2023 09:42

(Alliance News) - Oxford Nanopore Technologies PLC on Thursday touted the progress of a research group in Australia that has just received genomic funding for a project using Oxford Nanopore sequencing technology. Read More

LONDON BROKER RATINGS: Goldman starts M&G at 'buy'; Citi hikes B&M

28th Nov 2023 09:27

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday: Read More

LONDON BROKER RATINGS: Diageo gets price target cuts; JPMorgan ups M&G

13th Nov 2023 09:45

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning: Read More

Oxford Nanopore gets bioMerieux backing as announces clinical foray

19th Oct 2023 09:48

(Alliance News) - Oxford Nanopore Technologies PLC shares surged after it received GBP70 million worth of backing from in vitro diagnostics partner bioMerieux SA. Read More

Oxford Nanopore first-half figures fall as Covid testing contract ends

6th Sep 2023 11:17

(Alliance News) - Oxford Nanopore Technologies PLC on Wednesday said revenue and profit fell in the first half as it came to the end of its Covid-19 testing contract. Read More

UK earnings, trading statements calendar - next 7 days

30th Aug 2023 15:42

Read More

Oxford Nanopore calms investor concern with robust half-year

17th Jul 2023 10:10

(Alliance News) - Oxford Nanopore Technologies PLC's decent first-half will soothe investor worries on life sciences market weakness and increased competition, analysts at Berenberg commented on Monday. Read More

Oxford Nanopore maintains outlook after "strong" half-year growth

17th Jul 2023 08:40

(Alliance News) - Oxford Nanopore Technologies PLC on Monday said it expects to report half-year growth and the nanopore sequencing firm backed yearly guidance. Read More

LONDON BROKER RATINGS: Redburn likes Entain; HSBC lifts FirstGroup

19th Jun 2023 09:10

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday: Read More

Oxford Nanopore Technologies launches Germany-based rare-disease study

12th Jun 2023 09:06

(Alliance News) - Oxford Nanopore Technologies PLC said on Monday said it has reached an agreement with a national German science program to launch a study of the potential applications for nanopore-based sequencing to understand rare diseases. Read More

London "still attractive" place to list, as IPO activity trickles back

8th Jun 2023 12:09

(Alliance News) - A recent revival of initial public offerings in London's equity markets is encouraging evidence that the city still holds appeal on the global stage, analysts contended. Read More

UK shareholder meetings calendar - next 7 days

5th Jun 2023 15:47

Read More

IN BRIEF: Oxford Nanopore signs deal with PathoQuest to develop test

12th May 2023 09:39

Oxford Nanopore Technologies PLC - Oxford, England-based company that develops and sells nanopore sequencing products - Signs a definitive deal with PathoQuest SAS to co-develop an 'integration site analysis' test. Says the test will provide a good manufacturing practice validated nanopore sequencing-based commercial testing service to the biopharma industry. Oxford Nanopore says the service is designed to address the needs of industrial developers and manufacturers of biological products. Read More

FTSE 100 Latest
Value9,478.19
Change51.20